GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (OSTO:ULTIo) » Definitions » Net Policyholder Benefits/Claims

Zelluna ASA (OSTO:ULTIO) Net Policyholder Benefits/Claims


View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Zelluna ASA Business Description

Industry
Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Zelluna ASA is a clinical-stage biotechnology company developing novel immunotherapies against cancer and the development of T-Cell Receptor Natural Killer cell therapies for the treatment of solid cancers. The company's current pipeline consists of allogeneic TCR-NK R&D programs ZI-MA4-1, ZI-KL1-1, and ZI-PR-1 targeting well validated antigens expressed across a broad range of solid tumors.